The Economic Consequences of Improving Sleep among the Urban Poor through Cognitive Behavioral Therapy for Insomnia

Last registered on July 22, 2026

Pre-Trial

Trial Information

General Information

Title
The Economic Consequences of Improving Sleep among the Urban Poor through Cognitive Behavioral Therapy for Insomnia
RCT ID
AEARCTR-0018309
Initial registration date
July 15, 2026

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
July 22, 2026, 8:16 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
University of Melbourne

Other Primary Investigator(s)

PI Affiliation
UCSD
PI Affiliation
University of Melbourne
PI Affiliation
Monash University

Additional Trial Information

Status
In development
Start date
2026-08-17
End date
2026-10-01
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Poor sleep is common among adults living and working in low-income urban settings, but there is little evidence on whether improving sleep changes health or economic outcomes in these contexts. Existing interventions have mostly tried to increase how long people sleep. This study instead evaluates a program that targets sleep quality. The program is adapted from Cognitive Behavioral Therapy for Insomnia (CBT-I), the standard non-drug treatment for insomnia in high-income countries, where it is typically delivered by trained clinicians over seven or more individual sessions. Our adaptation condenses the core content into four weekly group sessions, delivered through pre-recorded video modules and trained lay facilitators rather than health professionals, and is designed for low-cost delivery.
Working with the Busara Center for Behavioral Economics, we recruit approximately 300 adults aged 18 to 45 with insomnia symptoms, drawn primarily from informal settlements in Nairobi. Participants are randomly assigned to one of two groups. The treatment group takes part in the four-week adapted program. The control group attends sessions on the same weekly schedule and completes surveys and other activities with no sleep or health content. All participants wear a wrist-worn sleep tracker for part of the study period, with devices rotated across the sample so that objective sleep data are collected for every participant. Everyone completes surveys before and after the intervention period. We measure effects on sleep (insomnia severity and device-measured sleep quality and duration), mental health (symptoms of depression and anxiety), cognitive performance, and productivity measured through incentivized tasks administered during study visits.
External Link(s)

Registration Citation

Citation
Drummond, Sean et al. 2026. "The Economic Consequences of Improving Sleep among the Urban Poor through Cognitive Behavioral Therapy for Insomnia." AEA RCT Registry. July 22. https://doi.org/10.1257/rct.18309-1.0
Sponsors & Partners

Sponsors

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
Experimental Details

Interventions

Intervention(s)
The intervention is a four-week group sleep improvement program adapted from Cognitive Behavioral Therapy for Insomnia (CBT-I). The standard clinical protocol, typically delivered by trained clinicians over seven or more individual sessions, was condensed into four weekly group sessions covering sleep efficiency, stimulus control, sleep hygiene, and stress management. Sessions are delivered through pre-recorded video modules and discussions led by trained lay facilitators. The control group attends sessions on the same weekly schedule and completes surveys and other activities with no sleep or health content.
Intervention Start Date
2026-08-17
Intervention End Date
2026-10-01

Primary Outcomes

Primary Outcomes (end points)
* Sleep: Insomnia Severity Index (ISI) score; device-measured sleep efficiency and sleep time from wrist-worn trackers
* Mental health: depression symptoms (PHQ-9) and anxiety symptoms (GAD-7)
* Cognitive performance: scores on attention and working memory tasks.
* Productivity: output and accuracy on incentivized effort tasks administered during study visits
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
* Self-reported labor market outcomes, including labor supply, earnings, missed workdays, perceived work performance, and job search effort
* Economic preference measures from incentivized tasks (risk and time preferences)
* Additional sleep and psychological measures, including sleep diaries, Fitbit-derived activity measures, perceived stress, and beliefs about sleep
Secondary Outcomes (explanation)

Experimental Design

Experimental Design

Participants who meet eligibility criteria, including a minimum insomnia symptom threshold, complete a baseline survey and are individually randomized to treatment or control. The treatment group receives the four-week group program described above; the control group attends sessions on the same schedule with no sleep or health content. All participants wear a wrist-worn sleep tracker for part of the study period, with devices rotated across the sample, and complete an endline survey after the intervention period
Experimental Design Details
Not available
Randomization Method
Randomization is performed at the individual level using statistical software (stratified by baseline insomnia severity, and gender.).
Treated participants are subsequently assigned at random to intervention session groups within their session-time cohort.
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
300 individuals (randomization is at the individual level, so clusters equal observations)
Sample size: planned number of observations
Approximately 300 adults (roughly 150 treatment, 150 control)
Sample size (or number of clusters) by treatment arms
150 treated participants, 150 control participants
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
University of California San Diego
IRB Approval Date
2026-07-08
IRB Approval Number
814983
IRB Name
Meru University Institutional Research & Ethics Review Committee
IRB Approval Date
2026-05-05
IRB Approval Number
MIRERC 027/2026
IRB Name
National Commission for Science, Technology and Innovation
IRB Approval Date
2026-06-10
IRB Approval Number
118492